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“If the best you can find is a case-control study, 
you must recognize that this is a weak design 
that often has led to erroneous conclusions.. ” 
D.L. Sackett, et al. (1985) [l] 
1. Introduction 
Few issues in epidemiology have led to more 
controversy than the validity of case-control stud- 
ies. This is illustrated by the above statements, 
drawn from two widely read textbooks in the field 
[1,2]. Some epidemiologists go as far as to strongly 
advise against reading, let alone conducting, a 
case-control study, especially when the study ob- 
jective is to assess causality or treatment efficacy 
[l]. They believe that bias inherent to this type of 
study makes the interpretation of its results virtu- 
ally impossible. Others have taken a less extreme 
point of view and emphasize both the limitations 
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“The sophisticated use and understanding of 
case-control studies is the most outstanding 
methodological development of modern epidemiology” 
K.J. Rothman (1986) 121 
and the potential of case-control studies [3,4]. 
Notwithstanding these opposing views, there can 
be no doubt that, since the publication of the first 
case-control study in 1920 [5], these studies have 
played an important role in the development of 
knowledge about the determinants of a variety of 
diseases. Important examples of their contribu- 
tion to clinical medicine include the studies on 
the causal relationship between blood transfu- 
sions and hepatitis, smoking habits and cancer of 
the lip or lung, the use of diethylstilbestrol during 
pregnancy and clear-cell adenocarcinoma of the 
vagina in offspring, exposure to radiation and 
leukaemia, and ABO blood type and venous 
thromboembolism. 
2. Essentials of the case-control study 
In essence, the case-control study is a formali- 
sation of the natural search for determinants of 
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disease as it occurs in day-to-day medical practice outcome under study, are identified and followed 
[4]. A physician wonders what may be the factor over time to establish whether they develop the 
underlying the occurrence of a particular disease, particular outcome. In case-control studies the 
and will attempt to identify common characteris- information on exposure is collected in all pa- 
tics in patients with the condition (“cases”) which tients who develop the outcome (“cases”) and in 
are not or less often present among those without a sample of the population from which the cases 
the condition (“controls”). The design of a case- emerge. It simply aims at abstracting the informa- 
control study is shown in Fig. 1. As in all types of tion on determinants in the whole of the study 
clinical epidemiological research the objective is population from which the cases came, by sam- 
to study the relationship between certain deter- pling from that population. Thus, a case-control 
minants and the occurrence of a disease. In the or case-referent study may be viewed as an effi- 
empirical situation of the actual research, the cient study design in which the level of exposure 
data on the exposure to the determinant and the to the determinant is measured in cases and 
outcome are then collected. The main difference controls only, whereas in a follow-up study or 
between a follow-up study and a randomized RCT the determinant is measured in the entire 
controlled trial (RCT) on the one hand, and a population. This is further illustrated in the Ap- 
case-control study on the other, lies in the way in pendix. As a consequence, a case-control study is 
which information is obtained. In the former types highly attractive when the outcome is rare. For 
of study, a group of subjects with and without the instance, a follow-up study on the association 
determinant, but not yet having experienced the between exposure to ultrasound during preg- 
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1 patientswithor (det , clis +) 
without the determinant 
but without the disease cases 
conbds or 
refenwts 
non-cmes 
Fig. 1. Study design of a case-control study. In a case-control study the information on exposure on the determinant (det) is 
collected in the cases, i.e. those who develop the disease (dis) under study, and in the controls, i.e. a sample of the study base from 
which the cases and non-cases emerge, only. Thus, in essence, the controls are not necessarily non-cases, but may become cases 
during the study period. 
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nancy and the occurrence of childhood leukaemia 
in the Netherlands would constitute unsurmount- 
able logistic problems in terms of following all 
pregnant Dutch women for a period up to 15 
years. The alternative, namely to identify all chil- 
dren with the diagnosis of leukaemia, and a con- 
trol group, and collecting information on expo- 
sure to ultrasound during pregnancy in these two 
groups only, is clearly more feasible. In contrast 
to a follow-up study and RCT, a case-control 
study, in general, does not provide absolute mea- 
sures of disease frequencies. The relationship be- 
tween determinant and outcome is quantified by 
the odds ratio, which is the ratio of the odds of 
exposure to the determinant in the cases, and the 
corresponding odds in the controls. Under cer- 
tain assumptions the odds ratio equals the inci- 
dence ratio, i.e. the disease rate (incidence) 
among exposed subjects relative to the disease 
rate among those not exposed to the determi- 
nant, and thus may be interpreted as a relative 
risk. The odds ratio can be easily derived from a 
Table 1 
Calculation of the odds ratios of lung cancer per category of 
smoking behaviour in men and women. 
Men 1,357 cases 1,357 controls odds ratio 
Smoking status 
One or more 99.5% (a) 95.5% (b) 9.0 
cigarettes/day 
Non-smoking 0.5% (cl 4.5% Cd) 1.0 
Women 108 cases 108 controls odds ratio 
Smoking status 
One or more 63.0% (a) 45.4% (b) 2.0 
cigarettes/day 
Non-smoking 37.0% (c) 54.6% (d) 1.0 
a+c b+d 
Non-smokers are considered as the reference category (odds 
ratio 1.0). The data are derived from a case-control study on 
smoking and lung cancer published by Doll and Hill in 1952 
[61. 
Odds ratio = exposure odds ratio = odds of exposure in 
cases/odds of exposure in controls = [(a /(a + c))/(c/(a + 
c))l/[(b/(b+d))/(d/(b+d)]=(a/c)/(b/d)=ad/bc 
Odds ratio of lung cancer of smoking compared to non-smok- 
ing men = ad/be = (99.5%.4.5%)/(95.5%.0.5%) = 
0.045/0.005 = 9.0 
Odds ratio of lung cancer in smoking compared to non-smok- 
ing women = ad/be = (99.5%.4.5%)/(95.5%.0.5%) = 
0.045/0.005 = 9.0 
two-by-two contingency table by calculating the 
cross-product. As an example, the odds ratio of 
lung cancer in smoking men and women is com- 
puted in Table 1, using data from a case-control 
study published in 1952 [6]. 
3. The history of case-control studies 
The case-control study as an option in study 
design was developed by sociologists at the begin- 
ning of the eighteenth century [7]. In the first 
case-control study in medicine published in 1920 
[5], smoking habits of 537 patients with epithe- 
lioma of the lip were compared to 500 patients 
“without” epithelioma. Although the percentage 
of smokers among cases and controls was similar 
(79% and 80%), a higher proportion of tobacco- 
consuming cases smoked a pipe (78%) compared 
to smoking controls (38%). 1950 heralded an im- 
portant period in clinical epidemiology in general 
and in the development of the case-control 
method in particular. In that year, 4 case-control 
studies assessing the association between tobacco 
consumption and the risk of cancer of the lung 
were published [g-11]. These early studies, al- 
though with methodological problems in several 
aspects, clearly illustrate the potential of this 
study design. In 1951, Cornfield gave a strong 
impulse to the application of the case-control 
method, by proving that, under the assumption 
that the outcome at interest is rare, the odds 
ratio equals the ratio of the incidences in exposed 
and the unexposed [12]. Another influential pa- 
per was published in 1959 when Mantel and 
Haenszel described a procedure to derive odds 
ratios from stratified data and thus enabled ad- 
justment for potential confounding variables [13]. 
During the last decades, case-control studies have 
been applied throughout the field of clinical 
medicine far beyond research on cancer aetiology 
for which it was first developed: e.g., in diagnostic 
research or in the evaluation of treatment effi- 
cacy or adverse effect. Especially in the latter 
field, the case-control method has proven its po- 
tential. Examples include studies on aspirin use 
and Reye’s syndrome [14], and, recently, beta- 
agonists and fatal asthma 1151. 
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4. The choice of a control group 
A crucial issue in the conduct of a case-control 
study is the choice of a proper control group. 
Using the case-base approach [3,16], controls 
should be sampled randomly from the study base, 
i.e. the whole population whose disease experi- 
ence is captured in a particular study (Fig. 1). 
Thus, valid sampling of controls involves a clear 
understanding of the definition of the study base. 
In practice, controls are usually sampled from the 
non-cases (i.e., patients who do not develop the 
outcome during the study period), rather than 
from the entire study base. In theory, this results 
in a biased estimate of the relative risk in that the 
odds ratio provides an overestimate of the dis- 
ease incidence ratio. This, however, does not lead 
to appreciable bias when the disease under study 
is rare (“rare disease assumption”). Alternative 
methods by which the odds ratio per definition 
provides an unbiased estimate of the incidence 
ratio include sampling of controls each time a 
case occurs in a dynamic population (when con- 
trols are, in principle, non-cases but may become 
cases later in the study period) or the case-cohort 
design [17]. In view of the specific characteristics 
of an empirical study general guidelines for valid 
sampling of the controls leading to preferential 
use of, e.g., neighbourhood, population, or hospi- 
tal controls, cannot be given. However, a useful 
rule of thumb is that subjects included in the 
control group should have been recognized as a 
case, and had this control experienced the out- 
come under study during the study period? When, 
for example, in a study on the relationship be- 
tween alcohol consumption and duodenal ulcer, 
the cases are derived from an outpatient clinic, 
the use of a random sample of the population at 
large as a control group seems inappropriate. 
Controls developing duodenal ulcer are unlikely 
to always have become a case in this study; e.g., 
because the general practitioner may decide to 
treat the patient without referral to a specialist. 
This could lead to an overestimation of the risk 
associated with alcohol intake, because patients 
attending an outpatient clinic may, irrespective of 
the presence of dyspepsia, have a higher level of 
alcohol consumption than the (relatively healthy) 
general population. This example also illustrates 
that the way in which both cases and controls 
come to the attention of the investigator should 
be independent of the exposure to the determi- 
nant. Dyspepsia patients with a history of alcohol 
consumption may be more likely to be referred, 
and thus become cases, than abstinent dyspepsia 
patients. 
The choice of the number of referents sampled 
per case differs among case-control studies. The 
ratio has no impact on the validity of the study 
but reflects a trade-off between the increase in 
precision of the estimate of the odds ratio (nar- 
rowing of the 95% confidence interval) and the 
cost in terms of time and money required to 
collect the information in more controls. It is 
generally accepted that a case/control ratio be- 
yond 1 to 5 does not appreciably add to the 
statistical power of a case-control study. A more 
controversial issue is the inclusion of several con- 
trol groups in a case-control comparison. In a 
study on aspirin and Reye’s syndrome, for exam- 
ple, 4 control groups were chosen [14]. In general, 
a clear understanding of the essentials of the 
study base will lead to sampling of one control 
group only. The inclusion of more control groups 
seems a waste of resources, and could, in case the 
odds ratios differ, hamper the interpretation of 
the results. Other authors argue that similar re- 
sults in several case-control comparisons within 
one study could increase the validity of the study. 
This, however, is more likely to be achieved by 
comparing the results of several case-control 
studies with valid sampling of one control group 
than by multiple case-control comparisons within 
one study. 
5. Advantages and disadvantages of case-control 
studies 
The main advantage of a case-control study is 
its efficiency. Information on exposure to a par- 
ticular determinant needs to be obtained in all 
cases and a sample of the reference population 
only. Thus, the costs of case-control studies are 
relatively low. Especially when the disease stud- 
ied is rare, the case-control approach offers obvi- 
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ous advantages compared to a‘follow-up study or 
RCT, and may even be the only feasible option in 
design. The important association between dieth- 
ylstilbestrol during pregnancy and the risk of 
vaginal carcinoma in daughters would never have 
received the attention it deserved without the 
publication of a case-control study on the puta- 
tive relation [18]. Another advantage of case-con- 
trol studies, although not often recognized, is the 
possibility of studying the influence of a wide 
variety of exposure levels (e.g., different dosages 
or duration of use of a particular drug) on the 
occurrence of an outcome. In contrast, there are 
several disadvantages inherent in case-control 
studies. In analogy to the efficiency of case-con- 
trol studies when the incidence of the outcome is 
low, the approach is less feasible when exposure 
to the determinant is rare. As indicated above, 
the choice of a proper control group is crucial to 
the validity of the study, but may pose important 
problems in practice. As a consequence, the 
method of sampling of the controls is often heav- 
ily criticized, although one sometimes gets the 
impression that this criticism is based on preju- 
dice concerning the invalidity of case-control 
studies in general than on the actual methodology 
of a particular study. Case-control studies are 
often considered to be more liable to bias, no- 
tably selection bias and recall bias, than alterna- 
tive designs [19]. Indeed, selection bias in case- 
control studies may occur when the selection of 
cases or controls is associated with the presence, 
or absence, of the determinant of interest. An 
example frequently cited is a case-control study 
assessing the relationship between the use of oral 
contraceptives and thromboembolism [20]. Physi- 
cians may be more prone to include thrombosis in 
the differential diagnosis and consequently per- 
form adequate diagnostic tests in women with 
prior use of contraceptives than in unexposed 
women. It should be stressed, however, that se- 
lection bias is a threat to validity in all types of 
(non-experimental) studies. A bias more particu- 
lar to case-control studies is recall bias. This type 
of information bias refers to the tendency of 
patients with a disease to recall an exposure to a 
particular determinant more often than subjects 
without the disorder, especially when an associa- 
tion between the determinant and the disease 
seems plausible. In a study on the relationship 
between head trauma and the occurrence of 
Alzheimer’s disease, relatives of patients with de- 
mentia are more likely to recall any head trauma 
than relatives of non-demented patients. A way 
to limit this type of bias would be to choose a 
control group of patients with a disease believed 
to be associated with head trauma by laymen but 
which is known to be unrelated to it (e.g., pa- 
tients with brain turnours). 
A final disadvantage of case-control studies, 
but also of other non-experimental studies, is the 
difficulty of ensuring validity when the objective 
is to assess treatment efficacy. Especially in com- 
paring the beneficial effect of treatment versus 
non-treatment, the lack of randomisation in these 
studies will almost certainly lead to baseline dif- 
ferences in prognosis between cases and controls. 
This will result in an underestimation of the 
beneficial effect of treatment. This phenomenon, 
which is caused by the natural tendency of physi- 
cians to treat those with a less favourable progno- 
sis (e.g., those who need treatment), is known as 
confounding by indication. Under these circum- 
stances, case-control studies could be of more 
value in the evaluation of the relative efficacy of 
different treatment regimes for a given indication 
ml. 
6. Conclusion 
In conclusion, case-control studies have proven 
to be an important tool in clinical epidemiological 
research, although their validity has been, and 
will be, criticized. The qualification of this type of 
study as a poor alternative to RCT’s and follow-up 
studies seems to be the result of an overemphasis 
of the disadvantages of the case-control method, 
without recognition of its important merits. A 
better understanding of the essentials of the 
case-control study, and its pitfalls as well as po- 
tentiaIs, may lead to more appropriate applica- 
tion and an even more prominent role of the 
case-control approach in clinical research. 
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Appendix: Case control summary 
The object of a follow-up study, or case-con- 
trol study, is to document the occurrence rela- 
tion: the occurrence of disease as a function of a 
certain determinant. 
The measure of association is the relative or 
absolute rate of disease in the presence or ab- 
sence of the determinant. In a follow-up study or 
RCT, in which information on the determinant is 
available on all participants, the basic results can 
be summarized in a two by two table. 
Disease No disease 
Determinant + a (N-a) N 
Determinant - b (N’-b) N’ 
----- 
(N+N’) 
The disease rates can easily be calculated as a/N 
in the exposed versus b/N’ in the unexposed. In 
a case-control study, interest is similarly in the 
disease rates. For these rates, as in follow-up 
studies or RCTs, the numerators are provided by 
the cases. 
Determinant + 
Determinant - 
Disease 
a 
b 
a+b 
cases 
However, in order to obtain denominators of the 
rates, a sample from the population is taken 
rather than the whole population. This control 
group, as it is representative of the population, 
has a distribution of the determinant that is simi- 
lar to the whole population. 
Determinant + it N 
Determinant - n’ N’ 
controls total population 
it is proportional to N, and it’ is proportional to 
N’. From these estimates of the whole population 
determinant distribution, estimates of the disease 
rates can be obtained (quasi-rates). Moreover, if 
the sampling fraction n or IZ’ is known, the true 
rates N, N’ can be obtained. 
In essence, contrary to common belief, in a 
case-control study cases are not compared to 
controls with respect to exposure, but cases pro- 
vide numerators and control denominators to es- 
timate disease rates in an efficient manner. The 
approach, however, is similar to that in follow-up 
studies and RCTs. 
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